| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
11.22(B) |
| Last
Volume: |
407,103 |
Avg
Vol: |
475,484 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
5 |
| Total Shares Sold |
1,636 |
25,558 |
49,996 |
92,833 |
| Total Sell Value |
$374,194 |
$6,377,856 |
$11,292,577 |
$21,658,880 |
| Total People Sold |
2 |
6 |
6 |
8 |
| Total Sell Transactions |
2 |
10 |
16 |
28 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-05-18 |
4 |
S |
$174.65 |
$61,128 |
D/D |
(350) |
9,637 |
|
-39% |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-05-18 |
4 |
AS |
$175.00 |
$3,051,125 |
D/D |
(17,435) |
229,894 |
|
39% |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-05-15 |
4 |
S |
$168.00 |
$2,594,170 |
D/D |
(15,418) |
9,987 |
|
-35% |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2020-05-15 |
4 |
OE |
$73.70 |
$511,045 |
D/D |
6,350 |
25,405 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
247,329 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2020-05-12 |
4 |
S |
$165.74 |
$129,277 |
D/D |
(780) |
21,837 |
|
-32% |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2020-05-11 |
4 |
S |
$160.85 |
$2,835,433 |
D/D |
(17,446) |
249,329 |
|
-33% |
|
| Chubb Stephen D |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
741 |
40,282 |
|
- |
|
| Andrews Nancy C |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
741 |
865 |
|
- |
|
| Wilson Virginia M |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
741 |
1,812 |
|
- |
|
| Mackay Martin |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,198 |
9,025 |
|
- |
|
| Bertolini Robert J |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,259 |
29,134 |
|
- |
|
| Reese C Richard |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,228 |
62,889 |
|
- |
|
| Milne George M Jr |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,380 |
28,417 |
|
- |
|
| Wallman Richard F |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,198 |
30,565 |
|
- |
|
| Massaro George |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
741 |
12,825 |
|
- |
|
| Kochevar Deborah Turner |
Director |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
741 |
9,047 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2020-05-07 |
4 |
AS |
$150.00 |
$282,600 |
D/D |
(1,884) |
18,591 |
|
58% |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2020-05-01 |
4 |
D |
$144.67 |
$8,970 |
D/D |
(62) |
1,930 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-03-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,151 |
12,151 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-03-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,151 |
5,899 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-03-05 |
4 |
S |
$164.09 |
$2,295,300 |
D/D |
(13,966) |
16,235 |
|
-20% |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2020-03-05 |
4 |
OE |
$73.70 |
$1,278,677 |
D/D |
12,467 |
30,201 |
|
- |
|
| Andrews Nancy C |
Director |
• • – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
124 |
124 |
|
- |
|
| Chubb Stephen D |
Director |
• • – |
2020-02-27 |
4 |
S |
$160.89 |
$396,437 |
D/D |
(2,464) |
39,541 |
|
-17% |
|
1166 Records found
|
|
Page 17 of 47 |
|
|
2.97 (1.4%) 
